GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Cash Flow for Dividends

Hualan Biological Engineering (SZSE:002007) Cash Flow for Dividends : ¥-468 Mil (TTM As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Cash Flow for Dividends?

Hualan Biological Engineering's cash flow for dividends for the three months ended in Dec. 2024 was ¥2 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was ¥-468 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Hualan Biological Engineering's quarterly payment of dividends declined from Jun. 2024 (¥-459 Mil) to Sep. 2024 (¥-4 Mil) and declined from Sep. 2024 (¥-4 Mil) to Dec. 2024 (¥2 Mil).

Hualan Biological Engineering's annual payment of dividends increased from Dec. 2022 (¥-399 Mil) to Dec. 2023 (¥-564 Mil) but then declined from Dec. 2023 (¥-564 Mil) to Dec. 2024 (¥-468 Mil).


Hualan Biological Engineering Cash Flow for Dividends Historical Data

The historical data trend for Hualan Biological Engineering's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Cash Flow for Dividends Chart

Hualan Biological Engineering Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -571.50 -564.11 -399.47 -563.64 -467.83

Hualan Biological Engineering Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.87 -6.28 -459.43 -4.19 2.07

Hualan Biological Engineering Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-468 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hualan Biological Engineering Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Engineering Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Executives
Chen Zheng Yue Executives
Fan Bei Directors, executives
Pan Ruo Wen Executives
Xie Jun Min Directors, executives
An Wen Qi Executives
An Kang Directors, executives
Ma Xiao Wei Executives
Zhang Bao Xian Executives
An Wen Jue Director
Liu Jun Executives
Wang Qi Ping Directors, executives
Lv Cheng Yu Securities Affairs Representative
Zhang Jin Gang Independent director
Wang Li Ting Independent director
Ma Li Supervisors

Hualan Biological Engineering Headlines

No Headlines